相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
4°C, protect from light
- 英文名:
LY2835219
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1231929-97-7
- 规格:
5 mg/10 mg/50 mg/100 mg/200 mg/500 mg/1 g
| 规格: | 5 mg | 产品价格: | ¥600.0 |
|---|---|---|---|
| 规格: | 10 mg | 产品价格: | ¥900.0 |
| 规格: | 50 mg | 产品价格: | ¥1200.0 |
| 规格: | 100 mg | 产品价格: | ¥1500.0 |
| 规格: | 200 mg | 产品价格: | ¥1900.0 |
| 规格: | 500 mg | 产品价格: | ¥3500.0 |
| 规格: | 1 g | 产品价格: | ¥5600.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Abemaciclib
CAS No. : 1231929-97-7
MCE 国际站:Abemaciclib
产品活性:Abemaciclib (LY2835219) 是具有选择性的 CDK4/6 抑制剂,能够抑制 CDK4/CDK6 的活性,IC50 分别为 2 nM 和 10 nM。
研究领域:Cell Cycle/DNA Damage
作用靶点:CDK
In Vitro: Abemaciclib reduces cell viability with the IC50 values ranging from 0.5 μM to 0.7 μM, inhibits Akt and ERK signaling but not mTOR activation at head and neck squamous cell carcinoma (HNSCC) cells. Abemaciclib shows inhibition on A375R1-4, M14R, and SH4R with EC50 values ranging from 0.3 to 0.6 μM; Abemaciclib inhibits the proliferation of the parental A375 and resistant A375RV1 and A375RV2 cells with similar potencies with IC50 values of 395, 260, and 463 nM, respectively. Abemaciclib inhibits CDK4 and CDK6 with low nanomolar potency, inhibits Rb phosphorylation resulting in a G1 arrest and inhibition of proliferation, and its activity is specific for Rb-proficient cells.
In Vivo: Abemaciclib (45 mg/kg, p.o.) in combination with RAD001 causes a cooperative antitumor effect in HNSCC xenograft tumor. Abemaciclib (45 or 90 mg/kg, p.o.) shows significant tumor growth inhibition in an A375 xenograft model.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Kinase Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | CNS-Penetrant Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Breast Cancer Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Targeted Therapy Drug Library | Rare Diseases Drug Library | EMA-Approved Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | Serine/Threonine Kinase Inhibitor Library | Palbociclib | Ro-3306 | Ribociclib | Dinaciclib | GSK3326595 | Abemaciclib methanesulfonate | THZ1 | Flavopiridol | SR-4835 | (R)-Roscovitine | THZ531 | AZD4573 | SY-5609 | Kenpaullone | Wogonin | SNS-032 | GSK 3 Inhibitor IX | Cirtuvivint | NVP-2 | Toyocamycin | Fadraciclib | Simurosertib | AT7519 | OTS964 hydrochloride | JNJ-7706621 | KB-0742 dihydrochloride | BSJ-4-116 | NG 52
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















